John Kwon

Array ( [id] => 6351452 [patent_doc_number] => 20100331288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'CRYSTALLINE HYDRATE OF BETAMIMETIKA AND USE AS MEDICAMENT THEREOF' [patent_app_type] => utility [patent_app_number] => 12/741090 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6311 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331288.pdf [firstpage_image] =>[orig_patent_app_number] => 12741090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228906 [patent_doc_number] => 07601719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Compounds, methods and pharmaceutical compositions for inhibiting PARP' [patent_app_type] => utility [patent_app_number] => 12/254356 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27485 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601719.pdf [firstpage_image] =>[orig_patent_app_number] => 12254356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352485 [patent_doc_number] => 20100331368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => '2,5-DIARYL SELENOPHENE COMPOUNDS, AZA 2,5-DIARYL THIOPHENE COMPOUNDS, AND THEIR PRODRUGS AS ANTIPROTOZOAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/680844 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20015 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331368.pdf [firstpage_image] =>[orig_patent_app_number] => 12680844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451399 [patent_doc_number] => 07964723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate' [patent_app_type] => utility [patent_app_number] => 12/253553 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4612 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964723.pdf [firstpage_image] =>[orig_patent_app_number] => 12253553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490875 [patent_doc_number] => 20090291946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 12/252700 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52967 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291946.pdf [firstpage_image] =>[orig_patent_app_number] => 12252700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317496 [patent_doc_number] => 08232272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same' [patent_app_type] => utility [patent_app_number] => 12/742375 [patent_app_country] => US [patent_app_date] => 2008-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27959 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12742375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7593195 [patent_doc_number] => 07652005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-26 [patent_title] => 'Tricyclic δ-opioid modulators' [patent_app_type] => utility [patent_app_number] => 12/248150 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43748 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/652/07652005.pdf [firstpage_image] =>[orig_patent_app_number] => 12248150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81841 [patent_doc_number] => 07745432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => '(1,10b-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo[1,5 C][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors' [patent_app_type] => utility [patent_app_number] => 12/241317 [patent_app_country] => US [patent_app_date] => 2008-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12253 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745432.pdf [firstpage_image] =>[orig_patent_app_number] => 12241317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527840 [patent_doc_number] => 08304410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto' [patent_app_type] => utility [patent_app_number] => 12/679848 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7077 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12679848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527968 [patent_doc_number] => 08304538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Method of producing benzoxazinone-based compound' [patent_app_type] => utility [patent_app_number] => 12/680377 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7566 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446324 [patent_doc_number] => 08288377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Inhibitors of the interaction between MDM2 and p53' [patent_app_type] => utility [patent_app_number] => 12/678680 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28755 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290987 [patent_doc_number] => 20090023717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'MORPHINE-BRIDGED INDAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/233138 [patent_app_country] => US [patent_app_date] => 2008-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7064 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023717.pdf [firstpage_image] =>[orig_patent_app_number] => 12233138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568112 [patent_doc_number] => 20100234363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'HETEROCYCLIC DERIVATIVE HAVING INHIBITORY ACTIVITY ON TYPE-I 11 DATA-HYDROXYSTEROID DEHYDROGENASE' [patent_app_type] => utility [patent_app_number] => 12/679159 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43276 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234363.pdf [firstpage_image] =>[orig_patent_app_number] => 12679159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8621515 [patent_doc_number] => 08354429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Inhibitors of human immunodeficiency virus replication' [patent_app_type] => utility [patent_app_number] => 12/742997 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38979 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12742997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189935 [patent_doc_number] => 20110172219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'CYANOAMINOQUINOLONES AND TETRAZOLOAMINOQUINOLONES AS GSK-3 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/677789 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17981 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172219.pdf [firstpage_image] =>[orig_patent_app_number] => 12677789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272197 [patent_doc_number] => 20090075973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'BENZO-FUSED HETEROCYCLES' [patent_app_type] => utility [patent_app_number] => 12/207601 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17944 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075973.pdf [firstpage_image] =>[orig_patent_app_number] => 12207601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497282 [patent_doc_number] => 20100286134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'NOVEL PHENOXAZIN-3-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/677053 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4172 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286134.pdf [firstpage_image] =>[orig_patent_app_number] => 12677053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995091 [patent_doc_number] => 08518975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Gamma secretase modulators' [patent_app_type] => utility [patent_app_number] => 12/673858 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89997 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214310 [patent_doc_number] => 08193181 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine' [patent_app_type] => utility [patent_app_number] => 12/676075 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9127 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193181.pdf [firstpage_image] =>[orig_patent_app_number] => 12676075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272215 [patent_doc_number] => 20090075991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED EFAVIRENZ' [patent_app_type] => utility [patent_app_number] => 12/196347 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2732 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075991.pdf [firstpage_image] =>[orig_patent_app_number] => 12196347 [rel_patent_id] =>[rel_patent_doc_number] =>)